Bayer AG of Germany is forming a joint venture in Mumbai with Cadila Healthcare Ltd to distribute pharmaceuticals in Indi.. Each company will hold 50 percent of the shares in the Mumbai-based venture, which will be called Bayer Zydus Pharma. The 600 person entity will focus on women’s healthcare, diagnostic imaging, cardiovascular diseases, anti-diabetic treatments, and oncology. Bayer HealthCare AG CEO Jorg Reinhardt said that the company aims to significantly accelerate their capabilities to better serve the fast growing Indian market.
Last updated: December 26th, 2025
